Endothelial dysfunction: a therapeutic target in bacterial sepsis?

References

• Jacob M, Chappell D, Becker BF. Regulation of blood flow and volume exchange across the microcirculation. Crit Care. 2016;20:319.
   PubMed Web of Science ®Google Scholar
• Wettschureck N, Strilic B, and Offermanns S. Passing the vascular barrier: endothelial signaling processes controlling extravasation. Physiol Rev. 2019;99:1467–1525.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Ince C, Mayeux PR, Nguyen T, et al. The endothelium in sepsis. Shock. 2016;45:259–270.
   PubMed Web of Science ®Google Scholar
• Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202:361–370
   PubMed Web of Science ®Google Scholar
• Bennett HS. Morphological aspects of extracellular polysaccharides. J Histochem Cytochem. 1963;11:14–23.
   Web of Science ®Google Scholar
• Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79:581–589.
   PubMed Web of Science ®Google Scholar
• Goligorsky MS, Sun D. Glycocalyx in endotoxemia and sepsis. Am J Pathol. 2020;190:791–798.
   PubMed Web of Science ®Google Scholar
• Uchimido R, Schmidt EP. Shapiro NI: the glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23:16.
   PubMed Web of Science ®Google Scholar
• Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008;29:572–576.
   PubMed Web of Science ®Google Scholar
• Rovas A, Seidel LM, Vink H, et al. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care. 2019;23:260.
   PubMed Web of Science ®Google Scholar
• Mishra HK, Ma J, Walcheck B. Ectodomain shedding by ADAM17: its role in neutrophil recruitment and the impairment of this process during sepsis. Front Cell Infect Microbiol. 2017;7:138.
   PubMed Web of Science ®Google Scholar
• Goldberg R, Meirovitz A, Hirshoren N, et al. Versatile role of heparanase in inflammation. Matrix Biol. 2013;32:234–240.
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18:1217–1223.
   PubMed Web of Science ®Google Scholar
• Hippensteel JA, Uchimido R, and Tyler PD, et al. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit Care. 2019;23:259.
   PubMed Web of Science ®Google Scholar
• Johansson PI, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194–200.
   PubMed Web of Science ®Google Scholar
• Fernandez-Sarmiento J, Salazar-Pelaez LM, Carcillo JA. The endothelial glycocalyx: a fundamental determinant of vascular permeability in sepsis. Pediatr Crit Care Med. 2020;21:e291–e300.
   PubMed Web of Science ®Google Scholar
• Johansen ME, Johansson PI, Ostrowski SR, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost. 2015;41:16–25.
   PubMed Web of Science ®Google Scholar
• Li X, Ma X. The role of heparin in sepsis: much more than just an anticoagulant. Br J Haematol. 2017;179:389–398.
   PubMed Web of Science ®Google Scholar
• Yini S, Heng Z, Xin A, et al. Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model. Acta Anaesthesiol Scand. 2015;59:160–169.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mu S, Li X, et al. Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J Surg Res. 2019;238:175–185.
   PubMed Web of Science ®Google Scholar
• Jaimes F, De La Rosa G, Morales C, et al. Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med. 2009;37:1185–1196.
   PubMed Web of Science ®Google Scholar
• Song JW, Zullo JA, Liveris D, et al. Therapeutic restoration of endothelial glycocalyx in sepsis. J Pharmacol Exp Ther. 2017;361:115–121.
   PubMed Web of Science ®Google Scholar
• Zhang C, Guo F, Chang M, et al. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-kappaB signaling axis and glycocalyx enhancement. Exp Cell Res. 2019;384:111596.
   PubMed Web of Science ®Google Scholar
• Ergin B, Guerci P, Zafrani L, et al. Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia. Intensive Care Med Exp. 2016;4:29.
   PubMedGoogle Scholar
• Lupu F, Kinasewitz G, Dormer K. The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis. J Cell Mol Med. 2020;24:12258–12271.
   PubMed Web of Science ®Google Scholar
• Flemming S, Burkard N, Renschler M, et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res. 2015;107:32–44.
   PubMed Web of Science ®Google Scholar
• Yu WK, McNeil JB, Wickersham NE, et al. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury. Crit Care. 2019;23:18.
   PubMed Web of Science ®Google Scholar
• Piotti A, Novelli D, Meessen JMTA, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Crit Care. 2021;25:113.
   PubMed Web of Science ®Google Scholar
• Zhang P, Peng J, Ren YQ, et al. Dexmedetomidine protects against endothelial injury in septic rats induced by cecal ligation and puncture by decreasing angiopoietin 2 and increasing vascular endothelial cadherin levels. Exp Ther Med. 2021;21:111.
   PubMed Web of Science ®Google Scholar
• She H, Zhu Y, Deng H, et al. Protective effects of dexmedetomidine on the vascular endothelial barrier function by inhibiting mitochondrial fission via ER/mitochondria contact. Front Cell Dev Biol. 2021;9:636327.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gupta E, Srivastava VK, et al. Nitrosative stress and cytokines are linked with the severity of sepsis and organ dysfunction. Br J Biomed Sci. 2019;76:29–34.
   PubMed Web of Science ®Google Scholar
• Giulivi C, Kato K, Cooper CE. Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. Am J Physiol Cell Physiol. 2006;291:C1225–C1231.
   PubMed Web of Science ®Google Scholar
• Ortiz F, Garcia JA, Acuna-Castroviejo D, et al. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res. 2014;56:71–81.
   PubMed Web of Science ®Google Scholar
• Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5:66–72.
   PubMed Web of Science ®Google Scholar
• Boughton-Smith NK, Evans SM, Laszlo F, et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol. 1993;110:1189–1195.
   PubMed Web of Science ®Google Scholar
• Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology. 1997;113:1246–1257.
   PubMed Web of Science ®Google Scholar
• Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818–2825.
   PubMed Web of Science ®Google Scholar
• Radomski MW, Vallance P, Whitley G, et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 1993;27:1380–1382.
   PubMed Web of Science ®Google Scholar
• Piepot HA, Groeneveld AB, Van Lambalgen AA, et al. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res. 2003;110:413–418.
   PubMed Web of Science ®Google Scholar
• Pleiner J, Mittermayer F, and Schaller G, et al. High doses of vitamin C reverse Escherichia coli endotoxin–induced hyporeactivity to acetylcholine in the human forearm. Circulation. 2002;106(12):1460–1464.
   PubMed Web of Science ®Google Scholar
• Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 2004;32:21–30.
   PubMed Web of Science ®Google Scholar
• Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A. 1994;91:12472–12476.
   PubMed Web of Science ®Google Scholar
• Wu CC, Chen SJ, Szabo C, et al. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol. 1995;114:1666–1672.
   PubMed Web of Science ®Google Scholar
• Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med. 1995;23:259–264.
   PubMed Web of Science ®Google Scholar
• Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860–1867.
   PubMed Web of Science ®Google Scholar
• Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A. 1990;87:10043–10047.
   PubMed Web of Science ®Google Scholar
• Legrand M, Kandil A, Payen D, et al. Effects of sepiapterin infusion on renal oxygenation and early acute renal injury after suprarenal aortic clamping in rats. J Cardiovasc Pharmacol. 2011;58:192–198.
   PubMed Web of Science ®Google Scholar
• Dumbarton TC, Maxan A, Farah N, et al. Tetrahydrobiopterin improves microcirculation in experimental sepsis. Clin Hemorheol Microcirc. 2017;67:15–24.
   PubMed Web of Science ®Google Scholar
• He X, Su F, Velissaris D, et al. Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shock. Crit Care Med. 2012;40:2833–2840.
   PubMed Web of Science ®Google Scholar
• Mittermayer F, Pleiner J, Schaller G, et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005;289:H1752–H1757.
   PubMed Web of Science ®Google Scholar
• Galley HF, Le Cras AE, Yassen K, et al. Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth. 2001;86:578–580.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Takano K, Teramae H, et al. Insights into sepsis therapeutic design based on the apoptotic death pathway. J Pharmacol Sci. 2010;114:354–365.
   PubMed Web of Science ®Google Scholar
• Stefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest. 2000;117:841–854.
   PubMed Web of Science ®Google Scholar
• Dolmatova EV, Wang K, Mandavilli R, et al. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021;117:60–73.
   PubMed Web of Science ®Google Scholar
• Zelic M, Roderick JE, O’Donnell JA, et al. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. J Clin Invest. 2018;128:2064–2075.
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99–109.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun B. Neutrophil pyroptosis: new perspectives on sepsis. Cell Mol Life Sci. 2019;76:2031–2042.
   PubMed Web of Science ®Google Scholar
• Ho J, Yu J, Wong SH, et al. Autophagy in sepsis: degradation into exhaustion? Autophagy. 2016;12:1073–1082.
   PubMed Web of Science ®Google Scholar
• Martich GD, Parker MM, and Cunnion RE, et al. Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol. 1985;1992:925–931.
   Google Scholar
• Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997;336:912–918.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Leder K, Woods RL, et al. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. Lancet Respir Med. 2021;9:186–195.
   PubMed Web of Science ®Google Scholar
• Wang X, Gao L, Xiao L, et al. 12(S)-hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury. J Diabetes Investig. 2019;10:639–649.
   PubMed Web of Science ®Google Scholar
• Dong R, Hu D, Yang Y, et al. EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway. Oncotarget. 2017;8:50958–50971.
   PubMedGoogle Scholar
• Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock. 1991;33:222–227.
   PubMedGoogle Scholar
• Weitzberg E, Hemsen A, Rudehill A, et al. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol. 1996;118:617–626.
   PubMed Web of Science ®Google Scholar
• Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov. 2017;16:635–661.
   PubMed Web of Science ®Google Scholar
• Akwii RG, Sajib MS, Zahra FT, et al. Role of angiopoietin-2 in vascular physiology and pathophysiology. Cells. 2019;8:471.
   PubMed Web of Science ®Google Scholar
• Hakanpaa L, Sipila T, Leppanen VM, et al. Endothelial destabilization by angiopoietin-2 via integrin beta1 activation. Nat Commun. 2015;6:5962.
   PubMed Web of Science ®Google Scholar
• Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006;12:235–239.
   PubMed Web of Science ®Google Scholar
• Yu WK, McNeil JB, Wickersham NE, et al. Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure. Crit Care. 2021;25:48.
   PubMed Web of Science ®Google Scholar
• Reilly JP, Wang F, Jones TK, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med. 2018;44:1849–1858.
   PubMed Web of Science ®Google Scholar
• Seol CH, Yong SH, Shin JH, et al. The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis. Cytokine. 2020;129:155029.
   PubMed Web of Science ®Google Scholar
• Ziegler T, Horstkotte J, Schwab C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest. 2013;123:3436–3445.
   Web of Science ®Google Scholar
• Han S, Lee SJ, Kim KE, et al. Amelioration of sepsis by TIE2 activation-induced vascular protection. Sci Transl Med. 2016;8:335ra55.
   PubMed Web of Science ®Google Scholar
• Idowu TO, Etzrodt V, and Seeliger B, et al. Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis. Elife. 2020;9:e59520 .
   PubMed Web of Science ®Google Scholar
• Pape T, Idowu TO, Etzrodt VM, et al. Modulation of the permeability-inducing factor angiopoietin-2 through bifonazole in systemic inflammation. Shock. 2021. https://doi.org/10.1097/SHK.0000000000001777. Online ahead of print.
   Google Scholar
• Gill SE, Rohan M, Mehta S. Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo. Respir Res. 2015;16:109.
   PubMed Web of Science ®Google Scholar
• Besnier E, Brakenhielm E, Richard V, et al. Does anti-VEGF bevacizumab improve survival in experimental sepsis? Crit Care. 2017;21:163.
   PubMed Web of Science ®Google Scholar
• Hauschildt J, Schrimpf C, Thamm K, et al. Dual pharmacological inhibition of angiopoietin-2 and VEGF-A in murine experimental sepsis. J Vasc Res. 2020;57:34–45.
   PubMed Web of Science ®Google Scholar
• van Lier D, Kox M, Pickkers P. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3. J Intern Med. 2021;289:792–806.
   PubMed Web of Science ®Google Scholar
• Marino R, Struck J, Maisel AS, et al. Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care. 2014;18:R34.
   PubMed Web of Science ®Google Scholar
• Mebazaa A, Geven C, Hollinger A, et al. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study. Crit Care. 2018;22:354.
   PubMed Web of Science ®Google Scholar
• Adrenomed: Positive Results from Adrenomed’s AdrenOSS-2 Phase II trial evaluating Adrecizumab (HAM8101) in Septic Shock presented during e-ISICEM. [cited 2021 Oct 7]. Available at: https://adrenomed.com/positive-results-from-adrenomeds-adrenoss-2-phase-ii-trial-evaluating-adrecizumab-ham8101-in-septic-shock-presented-during-e-isicem/
   Google Scholar
• Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–1125.
   PubMed Web of Science ®Google Scholar
• Sun Q, Dimopoulos G, Nguyen DN, et al. Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med. 2003;168:481–486.
   PubMed Web of Science ®Google Scholar
• Rehberg S, Yamamoto Y, Sousse L, et al. Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ Physiol. 2012;303:H1245–H1254.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Marinova M, Solopov P, et al. Protective mechanism of the selective vasopressin V1A receptor agonist selepressin against endothelial barrier dysfunction. J Pharmacol Exp Ther. 2020;375:286–295.
   PubMed Web of Science ®Google Scholar
• He X, Su F, Taccone FS, et al. A selective V1A receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock. Crit Care Med. 2016;44:23–31.
   PubMed Web of Science ®Google Scholar
• Russell JA, Vincent JL, Kjolbye AL, et al. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care. 2017;21:213.
   PubMed Web of Science ®Google Scholar
• Laterre PF, Berry SM, Blemings A, et al. Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA. 2019;322:1476–1485.
   PubMed Web of Science ®Google Scholar
• McDonald B, Davis RP, Kim SJ, et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood. 2017;129:1357–1367.
   PubMed Web of Science ®Google Scholar
• Mavrommatis AC, Theodoridis T, Economou M, et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med. 2001;27:1853–1859.
   PubMed Web of Science ®Google Scholar
• Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021;137:103–114.
   PubMed Web of Science ®Google Scholar
• Shriver Z, Liu D, Sasisekharan R. Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc Med. 2002;12:71–77.
   PubMed Web of Science ®Google Scholar
• Tipoe TL, Wu WKK, Chung L, et al. Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality outcomes: a systematic review and meta-analysis. Front Immunol. 2018;9:1218.
   PubMed Web of Science ®Google Scholar
• Levi M, Van Der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44.
   PubMed Web of Science ®Google Scholar
• Joffre J, Hellman J, and Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202:361–370.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Yamakawa K, Ogura H, et al. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation. Shock. 2015;43:443–449.
   PubMed Web of Science ®Google Scholar
• Iba T, Ogura H. Role of extracellular vesicles in the development of sepsis-induced coagulopathy. J Intensive Care. 2018;6:68.
   PubMed Web of Science ®Google Scholar
• Ito T, Kakuuchi M, Maruyama I. Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation. Crit Care. 2021;25:95.
   PubMed Web of Science ®Google Scholar
• Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286:1869–1878.
   PubMed Web of Science ®Google Scholar
• Kienast J, Juers M, Wiedermann CJ, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90–97.
   PubMed Web of Science ®Google Scholar
• Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003;290:238–247.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055–2064.
   PubMed Web of Science ®Google Scholar
• Healy LD, Puy C, Fernandez JA, et al. Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J Biol Chem. 2017;292:8616–8629.
   PubMed Web of Science ®Google Scholar
• Vincent JL. The rise and fall of drotrecogin alfa (activated). Lancet Infect Dis. 2012;12:649–651.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Francois B, Zabolotskikh I, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321:1993–2002.
   PubMed Web of Science ®Google Scholar
• Levi M, Vincent JL, Tanaka K, et al. Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy. Crit Care Med. 2020;48:1140–1147.
   PubMed Web of Science ®Google Scholar
• Umemura Y, Yamakawa K, Ogura H, et al. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2016;14:518–530.
   PubMed Web of Science ®Google Scholar
• Ergin B, Guerci P, Uz Z, et al. Hemodilution causes glycocalyx shedding without affecting vascular endothelial barrier permeability in rats. J Clin Trans Res. 2020;5:243–252.
   Google Scholar
• Saoraya J, Wongsamita L, Srisawat N, et al. Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis. Am J Emerg Med. 2021;42:83–89.
   PubMed Web of Science ®Google Scholar
• Aldecoa C, Llau JV, Nuvials X, et al. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;10:85.
   PubMed Web of Science ®Google Scholar
• Hariri G, Joffre J, Deryckere S, et al. Albumin infusion improves endothelial function in septic shock patients: a pilot study. Intensive Care Med. 2018;44:669–671.
   PubMed Web of Science ®Google Scholar
• Kremer H, Baron-Menguy C, Tesse A, et al. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties. Crit Care Med. 2011;39:1414–1422.
   PubMed Web of Science ®Google Scholar
• Muller RB, Ostrowski SR, Haase N, et al. Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. J Crit Care. 2016;32:16–20.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Moore EE, McLaughlin NJ, et al. Hyperosmolarity attenuates TNF-alpha-mediated proinflammatory activation of human pulmonary microvascular endothelial cells. Shock. 2013;39:366–372.
   PubMed Web of Science ®Google Scholar
• Besnier E, Coquerel D, Kouadri G, et al. Hypertonic sodium lactate improves microcirculation, cardiac function, and inflammation in a rat model of sepsis. Crit Care. 2020;24:354.
   PubMed Web of Science ®Google Scholar
• Salgado DR, Rocco JR, Silva E, et al. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets. 2010;14:11–20.
   PubMed Web of Science ®Google Scholar
• Leisman DE, Fernandes TD, Bijol V, et al. Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury. Kidney Int. 2021;99:148–160.
   PubMed Web of Science ®Google Scholar
• Zielinska KA, Van ML, Opdenakker G, et al. Endothelial response to glucocorticoids in inflammatory diseases. Front Immunol. 2016;7:592.
   PubMed Web of Science ®Google Scholar
• Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009;104:78–89.
   PubMed Web of Science ®Google Scholar
• Liu SF, Ab M. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol. 2006;290:L622–L645.
   PubMed Web of Science ®Google Scholar
• Heming N, Sivanandamoorthy S, Meng P, et al. Immune effects of corticosteroids in sepsis. Front Immunol. 2018;9:1736.
   PubMed Web of Science ®Google Scholar
• Duma D, Silva-Santos JE, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats. Crit Care Med. 2004;32:2304–2310.
   PubMed Web of Science ®Google Scholar
• Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871.
   PubMed Web of Science ®Google Scholar
• Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809–818.
   PubMed Web of Science ®Google Scholar
• May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19:2068–2083.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Khangoora V, Marik PE, et al. Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest. 2017;152:954–962.
   PubMed Web of Science ®Google Scholar
• Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151:1229–1238.
   PubMed Web of Science ®Google Scholar
• Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323:423–431.
   PubMed Web of Science ®Google Scholar
• Sevransky JE, Rothman RE, Hager DN, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325:742–750.
   PubMed Web of Science ®Google Scholar
• Jaimes EA, Hua P, Tian RX, et al. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol. 2010;298:F125–F132.
   PubMed Web of Science ®Google Scholar
• Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277–2286.
   PubMed Web of Science ®Google Scholar
• Zuurbier CJ, Demirci C, Koeman A, et al. Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. J Appl Physiol. 1985;2005(99):1471–1476.
   Google Scholar
• Caldwell A, Morick JN, Jentsch AM, et al. Impact of insulin on the intestinal microcirculation in a model of sepsis-related hyperglycemia. Microvasc Res. 2018;119:117–128.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Nishiwaki T, Sekine A, et al. Vascular repair by tissue-resident endothelial progenitor cells in endotoxin-induced lung injury. Am J Respir Cell Mol Biol. 2015;53:500–512.
   PubMed Web of Science ®Google Scholar
• Cao JP, He XY, Xu HT, et al. Autologous transplantation of peripheral blood-derived circulating endothelial progenitor cells attenuates endotoxin-induced acute lung injury in rabbits by direct endothelial repair and indirect immunomodulation. Anesthesiology. 2012;116:1278–1287.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Crit Care. 2019;23:44.
   PubMed Web of Science ®Google Scholar
• Mathiesen A, Hamilton T, Carter N, et al. Endothelial extracellular vesicles: from keepers of health to messengers of disease. Int J Mol Sci. 2021;22:4640.
   PubMed Web of Science ®Google Scholar
• Bellingan G, Maksimow M, Howell DC, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. Lancet Respir Med. 2014;2:98–107.
   PubMed Web of Science ®Google Scholar
• Yoo CH, Yeom JH, Heo JJ, et al. Interferon beta protects against lethal endotoxic and septic shock through SIRT1 upregulation. Sci Rep. 2014;4:4220.
   PubMed Web of Science ®Google Scholar
• Bellingan G, Maksimow M, Howell DC, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. Lancet Respir Med. 2014;2:98–107.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Pettila V, Karvonen MK, et al. Effect of intravenous interferon beta-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2020;323:725–733.
   PubMed Web of Science ®Google Scholar
• Clere-Jehl R, Merdji H, Kassem M, et al. A translational investigation of IFN-alpha and STAT1 signaling in endothelial cells during septic shock provides therapeutic perspectives. Am J Respir Cell Mol Biol. 2021;65:167–175.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Wang YC, Liu QX, et al. FK866 attenuates sepsis-induced acute lung injury through c-jun-N-terminal kinase (JNK)-dependent autophagy. Life Sci. 2020;250:117551.
   PubMed Web of Science ®Google Scholar
• Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev. 2000;80:1669–1699.
   PubMed Web of Science ®Google Scholar
• Ashraf MA, Nookala V. Biochemistry of platelet activating factor. StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2021: Jan–. PMID: 32491324.
   Google Scholar
• Yost CC, Weyrich AS, Zimmerman GA. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie. 2010;92:692–697.
   PubMed Web of Science ®Google Scholar
• Schuster DP, Metzler M, Opal S, et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med. 2003;31:1612–1619.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Spapen H, Bakker J, et al. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. Crit Care Med. 2000;28:638–642.
   PubMed Web of Science ®Google Scholar
• Brizzi MF, Battaglia E, Montrucchio G, et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ Res. 1999;84:785–796.
   PubMed Web of Science ®Google Scholar
• Zakynthinos SG, Papanikolaou S, Theodoridis T, et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med. 2004;32:1004–1010.
   PubMed Web of Science ®Google Scholar
• Cuccurullo A, Greco E, Lupia E, et al. Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis. PLoS One. 2016;11:e0151088.
   PubMed Web of Science ®Google Scholar
• Wang L, Huang X, Kong G, et al. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS. Biochem Biophys Res Commun. 2016;478:669–675.
   PubMed Web of Science ®Google Scholar
• Truwit JD, Bernard GR, Steingrub J, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191–2200.
   PubMed Web of Science ®Google Scholar
• Patel JM, Snaith C, Thickett DR, et al. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). Crit Care. 2012;16:R231.
   PubMed Web of Science ®Google Scholar
• Hotta K, Behnke BJ, Arjmandi B, et al. Daily muscle stretching enhances blood flow, endothelial function, capillarity, vascular volume and connectivity in aged skeletal muscle. J Physiol. 2018;596:1903–1917.
   PubMed Web of Science ®Google Scholar
• Tyml K, Swarbreck S, Pape C, et al. Voluntary running exercise protects against sepsis-induced early inflammatory and pro-coagulant responses in aged mice. Crit Care. 2017;21:210.
   PubMed Web of Science ®Google Scholar
• Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24:287.
   PubMed Web of Science ®Google Scholar
• Tremblay JC, Pyke KE. Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans? Am J Physiol Heart Circ Physiol. 2018;314:H508–H520.
   PubMed Web of Science ®Google Scholar
• Rosenberry R, Nelson MD. Reactive hyperemia: a review of methods, mechanisms, and considerations. Am J Physiol Regul Integr Comp Physiol. 2020;318:R605–R618.
   PubMed Web of Science ®Google Scholar
• Sturm T, Leiblein J, Schneider-Lindner V, et al. Association of microcirculation, macrocirculation, and severity of illness in septic shock: a prospective observational study to identify microcirculatory targets potentially suitable for guidance of hemodynamic therapy. J Intensive Care Med. 2018;33:256–266.
   PubMed Web of Science ®Google Scholar
• De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98–104.
   PubMed Web of Science ®Google Scholar
• Bourcier S, Joffre J, Dubee V, et al. Marked regional endothelial dysfunction in mottled skin area in patients with severe infections. Crit Care. 2017;21:155.
   PubMed Web of Science ®Google Scholar
• Ince C, Boerma EC, Cecconi M, et al. Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2018;44:281–299.
   PubMed Web of Science ®Google Scholar
• Rovas A, Seidel LM, Vink H, et al. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care. 2019;23:260.
   PubMed Web of Science ®Google Scholar
• Uz Z, Ince C, Shen L, et al. Real-time observation of microcirculatory leukocytes in patients undergoing major liver resection. Sci Rep. 2021;11:4563.
   PubMed Web of Science ®Google Scholar
• Favaron E, Ince C, Hilty MP, et al. Capillary leukocytes, microaggregates, and the response to hypoxemia in the microcirculation of coronavirus disease 2019 patients. Crit Care Med. 2021;49:661–670.
   PubMed Web of Science ®Google Scholar
• Marini JJ, Gattinoni L, Ince C, et al. A few of our favorite unconfirmed ideas. Crit Care. 2015;19(Suppl 3):S1.
   PubMedGoogle Scholar
• Chia PY, Teo A, Yeo TW. Overview of the assessment of endothelial function in humans. Front Med (Lausanne). 2020;7:542567.
   PubMed Web of Science ®Google Scholar
• Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Crit Care. 2014;18:460.
   PubMed Web of Science ®Google Scholar
• Ince C. Physiology and technology for the ICU in vivo. Crit Care. 2019;23:126.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Forni LG, Busse LW, et al. Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med. 2020;202:1253–1261.
   PubMed Web of Science ®Google Scholar